tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Income Statement

Compare
312 Followers

Keros Therapeutics Income Statement

Last quarter (Q4 2024), Keros Therapeutics's total revenue was $3.04M, an increase of 2027.27% from the same quarter last year. In Q4, Keros Therapeutics's net income was $-46.03M. See Keros Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.55M$ 151.00K$ 0.00$ 20.10M$ 0.00
Gross Profit
$ 3.55M$ -664.00K$ -1.61M$ 19.20M$ -605.00K
Operating Expenses
$ 214.38M$ 170.09M$ 107.71M$ 76.47M$ 44.20M
Depreciation and Amortization
$ 1.23M$ 815.00K$ 1.61M$ 898.00K$ 605.00K
EBITDA
$ -185.82M$ -152.18M$ -103.06M$ -56.37M$ -44.92M
Operating Income
$ -210.83M$ -169.94M$ -114.79M$ -56.37M$ -46.66M
Other Income/Expenses
$ 23.78M$ 16.95M$ 10.11M$ -360.00K$ 1.12M
Pretax Income
$ -187.05M$ -152.99M$ -104.68M$ -56.73M$ -45.53M
Net Income
$ -187.35M$ -152.99M$ -104.68M$ -58.74M$ -45.36M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.00$ -5.20$ -4.15$ -2.52$ -2.93
Diluted EPS
$ -5.00$ -5.20$ -4.15$ -2.52$ -2.93
Weighted Average Shares Outstanding
37.44M 29.45M 25.24M 23.33M 15.51M
Weighted Average Shares Outstanding (Diluted)
37.44M 29.45M 25.24M 23.33M 15.51M
Currency in USD

Keros Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis